Published in Healthcare Mergers, Acquisitions and Ventures Week, January 14th, 2006
The underwriting syndicate agreed to purchase 6,250,000 common shares from AnorMED, on a bought deal basis, and sell to the public at a price of $4.00 per common share, representing an aggregate issue amount of $25,000,000.
As well, the underwriters have exercised their option under the underwriting agreement to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week